Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Evidence strongly supports the important role of insulin resistance in cognitive decline and dementia and suggests that insulin sensitizers may protect against cognitive decline in diabetic and pre-diabetic individuals. Inconclusive results have been reported in clinical trials of rosiglitazone, an insulin sensitizer that also increases cardiovascular mortality risks. No study has yet reported a protective cognitive effect of metformin, an insulin-sensitizing biguanide widely used in diabetic patients. We studied 365 older persons aged 55 and over in the population-based Singapore Longitudinal Aging Study with diabetes who were followed up over 4 years. The odds ratios (OR) of association of metformin use (n = 204) versus non-use (n = 161) with cognitive impairment (Mini-Mental State Exam ≤ 23), and by duration: up to 6 years (n = 114) and more than 6 years (n = 90) were evaluated in cross-sectional and longitudinal multivariate analyses. Controlling for age, education, diabetes duration, fasting blood glucose, vascular and non-vascular risk factors, metformin use showed a significant inverse association with cognitive impairment in longitudinal analysis (OR = 0.49, 95% CI 0.25-0.95). Metformin use showed significant linear trends of association across duration of use in cross-sectional and longitudinal analyses (p = 0.018 and p = 0.002, respectively), with use for more than 6 years significantly associated with lowest risk of cognitive impairment in both cross-sectional anal…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [304]
In the citing paper
“In the Singapore Longitudinal Aging Study 2,365 subjects with diabetes (age ≥ 55) were monitored for 4 years – see Table 2 (116). In a cross-sectional and longitudinal multivariate analysis, odds ratios of association of the chronic use of metformin with cognitive disability (Mini-Mental State Exam ≤ 23) were evaluated demonstrating a substantial inverse relationship with cognitive impairment (116”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [116]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 2×
“Metformin has also been shown to attenuate inflammation in experimental models of central inflammation by modulating proinflammatory responses in rat primary microglia cells through both AMPK-dependent and AMPK-independent mechanisms [36].”
BackgroundAppendix G: Geriatric Depression Scale
(2015) · Deep Brain Stimulation Management · doi:10.1017/cbo9781316026625.021 · Cited by 1,536
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“This is responsible for the known effects of metformin in inhibiting hepatic glucose production, increasing insulin sensitivity, enhancing peripheral utilization of glucose (from improved insulin binding to insulin receptors), and increasing fatty acid oxidation [31], leading to improved glycemic and lipid profiles fr…”
BackgroundCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Cited by
Items 201–300 of 359
Daniel, J. M., Lindsey, S. H., Mostany, R., Schrader, L. A., & Zsombok, A. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101068 · Cited by 20
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Hu, L., Wang, W., Chen, X., Bai, G., Ma, L., Yang, X., Shu, Q., & Li, X. (2024) · Brain‐X · doi:10.1002/brx2.52 · Cited by 20
Ismail, T. R., Yap, C. G., Naidu, R., Shri, L., & Pamidi, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116729 · Cited by 20
Cozza, A., Chinigò, C., Filicetti, E., Greco, G. I., Lappano, R., Marinaro, C., Muglia, L., Soraci, L., Corsonello, A., Lattanzio, F., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102834 · Cited by 20
Maddaloni, E., D’Onofrio, L., & Pozzilli, P. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2762 · Cited by 20
Robbins, J., Busquets, O., Tong, M., & de la Monte, S. M. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200238 · Cited by 20
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 19
Metformin and Dementia Risk: A Systematic Review with Respect to Time Related Biases
Dai, J., Ports, K. D., Corrada, M. M., Odegaard, A., O’Connell, J., & Jiang, L. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220002 · Cited by 19
Umegaki, H. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0375-0 · Cited by 19
Soldevila‐Domenech, N., Cuenca‐Royo, A., Babió, N., Forcano, L., Nishi, S. K., Vintró‐Alcaraz, C., Martínez, C. G., Jiménez‐Múrcia, S., Fernández-Carrión, R., Gomis‐González, M., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.742586 · Cited by 19
Metabolic Alterations at the Crossroad of Aging and Oncogenesis
Raffaghello, L., & Longo, V. D. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.003 · Cited by 19
Gedawy, A., Al‐Salami, H., & Dass, C. R. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0102 · Cited by 19
New Horizons in the Management of Alzheimer Disease
Morley, J. E. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.022 · Cited by 18
Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia
Goodall, L., Lennon, M. J., Sachdev, P. S., Gorelick, P. B., Kovacic, J. C., & Samaras, K. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.1502 · Cited by 17
Disrupting the Mood and Obesity Cycle: The Potential Role of Metformin
Doan, S. N., Patel, S. K., Xie, B., Nelson, R. A., & Yee, L. D. (2023) · Obesities · doi:10.3390/obesities3010006 · Cited by 17
Metformin mitigates dementia risk among individuals with type 2 diabetes
Aderinto, N., Olatunji, G. D., Kokori, E., Fawehinmi, P., Moradeyo, A. A., Igwe, S. C., Ojabo, R. E., Alabi, B. O., Okafor, E. C., Ologbe, D., et al. (2024) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-024-00168-7 · Cited by 17
Zhao, R. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00428-7 · Cited by 18
New Horizons—Cognitive Dysfunction Associated With Type 2 Diabetes
Moran, C., Than, S., Callisaya, M. L., Beare, R. J., & Srikanth, V. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab797 · Cited by 17
Is metformin a geroprotector? A peek into the current clinical and experimental data
Zajda, A., Huttunen, K. M., Sikora, J., Podsiedlik, M., & Markowicz-Piasecka, M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111350 · Cited by 16
Das, S., Ramachandran, A. K., Halder, D., Akbar, S., Ahmed, B., & Joseph, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220629162229 · Cited by 16
Metformin use and brain atrophy in nondemented elderly individuals with diabetes
Nabizadeh, F., Kankam, S. B., Balabandian, M., Hashemi, S. M., Sharifkazemi, H., & Rostami, M. R. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111890 · Cited by 16
Kaufmann, G. T., Hyman, M. J., Gonnah, R., Hariprasad, S. M., & Skondra, D. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.11.22 · Cited by 16
Chang, M. H., Park, J. H., Lee, H., Choi, J. Y., & Koh, Y. H. (2024) · Biomedicines · doi:10.3390/biomedicines12061223 · Cited by 16
del Ser, T., Zea‐Sevilla, M. A., Valentí, M., Olazarán, J., López‐Álvarez, J., Rebollo-Vázquez, A., Ávila‐Villanueva, M., Frades, B., Medina, M., & Fernández‐Blázquez, M. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119857206 · Cited by 16
Matsubayashi, S., Ito, S., Araya, J., & Kuwano, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1079626 · Cited by 15
Changes of glucose levels precede dementia in African‐Americans with diabetes but not in Caucasians
Hendrie, H. C., Zheng, M., Lane, K. A., Ambuehl, R. J., Purnell, C. E., Li, S., Unverzagt, F. W., Murray, M. D., Balasubramanyam, A., Callahan, C., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.03.008 · Cited by 15
Hao, L., Li, Q., Zhao, X., Li, Y., & Zhang, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.006 · Cited by 15
Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases
Hölscher, C. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.007 · Cited by 15
Rahman, S. O., Khan, T. M., Iqubal, A., Agarwal, S., Akhtar, M., Parvez, S., Shah, Z. A., & Najmi, A. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121899 · Cited by 15
Diniz, B. S., Seitz‐Holland, J., Sehgal, R., Kasamoto, J., Higgins‐Chen, A., & Lenze, E. J. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.09.014 · Cited by 15
Lee, H., & Kim, E. Y. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01268-5 · Cited by 15
AMPK activators for the prevention and treatment of neurodegenerative diseases
Neumann, N. R., Thompson, D. C., & Vasiliou, V. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1991308 · Cited by 15
Effects of lifespan-extending interventions on cognitive healthspan
Čulig, L., Sahbaz, B. D., & Bohr, V. A. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.36 · Cited by 14
Motamed‐Jahromi, M., Kaveh, M. H., & Vitale, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-64314-y · Cited by 14
He, Y., Li, Z., Shi, X., Ding, J., & Wang, X. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231175189 · Cited by 14
Drug interactions with dementia‐related pathophysiological pathways worsen or prevent dementia
Barus, R., Béné, J., Deguil, J., Gautier, S., & Bordet, R. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14607 · Cited by 14
Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240495 · Cited by 13
Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 13
New Insight into Metformin Mechanism of Action and Clinical Application
Yan, Y., Kover, K. L., & Moore, W. V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91148 · Cited by 13
Chen, P.-C., Hong, C.-T., Chen, W.-T., Chan, L., & Chien, L.-N. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.01.007 · Cited by 12
You, M., Wu, F., Xiong, F., Hu, X., Wu, H., Zhou, L., & Zhang, H. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5686 · Cited by 12
Insulin, Brain, Alzheimer’s Disease: New Evidence
Bulgakova, S. V., Иванович, Р. П., & Treneva, E. V. (2020) · Bulletin of Science and Practice · doi:10.33619/2414-2948/52/10 · Cited by 12
Polyoxidovanadates as a pharmacological option against brain aging
Díaz, A., Vázquez‐Roque, R. A., Carreto-Meneses, K., Moroni-González, D., Moreno-Rodríguez, J. A., & Treviño, S. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102256 · Cited by 12
Triad of impairment in older people with diabetes-reciprocal relations and clinical implications
Abdelhafiz, A. H., Davies, P. C., & Sinclair, A. J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108065 · Cited by 11
Anti-diabetics and the Prevention of Dementia: A Systematic Review
Slouha, E., Ibrahim, F., Rezazadah, A., Esposito, S., Clunes, L. A., & Kollias, T. F. (2023) · Cureus · doi:10.7759/cureus.49515 · Cited by 11
The NDR family of kinases: essential regulators of aging
Jonischkies, K., del Ángel, M., Demiray, Y. E., Zambrano, A. L., & Stork, O. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1371086 · Cited by 10
The role of antidiabetic drugs in the treatment of Alzheimer’s disease: systematic review
Ishmuratova, A. N., Abramov, M. A., Олегович, К. К., Ivanyuta, M. V., Shakirova, Z. F., Kitapova, A. I., Usmonov, M., Chernousova, L. M., Valeeva, L. I., Kuznetsova, A. Y., et al. (2023) · Problems of Endocrinology · doi:10.14341/probl13183 · Cited by 10
Когнітивні порушення при цукровому діабеті типу 2: роль гіпоглікемізуючої терапії
Pashkovska, N. V. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.1.2018.127097 · Cited by 10
Diabetes and dementia – the two faces of Janus
Papazafiropoulou, A. K., Koros, C., Melidonis, A. J., & Antonopoulos, S. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.97433 · Cited by 10
Diabetes mellitus and cognitive impairment
Surkova, E. V., Tanashyan, M. М., Bespalov, A. I., & Naminov, A. V. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.10.000362 · Cited by 10
Metformin attenuates white matter microstructural changes in Alzheimer’s disease
Abbaszadeh, S., Dehaghi, G. R., Lalaklou, Z. G., Verdi, H. B., Emami, D., & Dalvandi, B. (2024) · Neurology Letters · doi:10.61186/nl.3.2.39 · Cited by 9
Lu, L., Mao, L., Yang, S., He, X., Zhang, Z., & Chen, N. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s439785 · Cited by 9
Alldred, M. J., Ibrahim, K. W., Pidikiti, H., Chiosis, G., Mufson, E. J., Stutzmann, G. E., & Ginsberg, S. D. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01891-z · Cited by 9
The Association Between Diabetes and Cognitive Function in Later Life
Momtaz, Y. A., Hamid, T. A., Bagat, M. F., & Hazrati, M. (2019) · Current Aging Science · doi:10.2174/1874609812666190614104328 · Cited by 9
Cognitive impairment in type 2 diabetes mellitus: prospects for the use of metformin
Pashkovska, N. V. (2023) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.3.2023.1274 · Cited by 10
Gosalia, J., Spicuzza, J. M. D., Bowlus, C. K., Pawelczyk, J. A., & Proctor, D. N. (2024) · GeroScience · doi:10.1007/s11357-024-01456-x · Cited by 8
The Effect of Type-2 Diabetes on Cognitive Status and the Role of Anti-diabetes Medications
Alkasabera, A., Onyali, C. B., Anim-Koranteng, C., Shah, H. E., Ethirajulu, A., Bhawnani, N., & Mostafa, J. A. (2021) · Cureus · doi:10.7759/cureus.19176 · Cited by 8
Intricacies of aging and Down syndrome
Kozlov, G., Franceschi, C., & Vedunova, M. V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105794 · Cited by 7
Senolytics: The Modern Snake Oil?
Morley, J. E. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1202-1 · Cited by 8
Low, S. K., Moh, A. M. C., Goh, K. S., Khoo, J., Ang, K., Liu, A. Y. L., Tang, W. E., Lim, Z., Subramaniam, T., Sum, C. F., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240067 · Cited by 6
Sex Differences in the Preventive Effect of Cardiovascular and Metabolic Therapeutics on Dementia
Choi, S. A., Jee, H. J., Bormate, K. J., Kim, Y., & Jung, Y.-S. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.115 · Cited by 6
The anti-aging role of metformin, clinical applications to pursue the longevity road
Pozzi, M., Susini, P., Seclì, D. D., Diluiso, G., Mendes, V. M., Grimaldi, L., & Schettino, M. (2024) · European Journal of Plastic Surgery · doi:10.1007/s00238-024-02211-3 · Cited by 6
Ostroumova, O. D., Surkova, E. V., Васильевна, Г. И., Starodubova, A. V., Кочетков, А. И., Kiknadze, T. D., & Galstyan, G. R. (2020) · Diabetes Mellitus · doi:10.14341/dm10202 · Cited by 6
Moh, M. C., Low, S. K., Ng, T. P., Ang, S. F., Ang, K., Sum, C. F., Subramaniam, T., & Lim, S. C. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200080 · Cited by 6
Self-citationNakatani, E., Ohno, H., Satoh, T., Funaki, D., Ueki, C., Matsunaga, T., Nagahama, T., Tonoike, T., Yui, H., Miyakoshi, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308734 · Cited by 5
Механізми дії метформіну за діабету та пов’язаних із діабетом патологій
SOKOLOVA, L. K., Pushkarev, V. M., & Ковзун, О. І. (2020) · Endokrynologia · doi:10.31793/1680-1466.2020.25-2.143 · Cited by 5
Masters, M. C., Granche, J., Yang, J., Overton, E. T., Letendre, S. L., Koletar, S. L., Rubin, L. H., Brown, T. T., Tassiopoulos, K., Erlandson, K. M., et al. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0129 · Cited by 5
Savva, K., Zachariou, M., Bourdakou, M. M., Dietis, N., & Spyrou, G. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105319 · Cited by 5
Sivadasan, S., Subramanian, M., & Aiyalu, R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99815 · Cited by 5
Lee, H. J., Choi, J. Y., Park, J. H., Chang, M. H., Park, J. H., & Koh, Y. H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336015 · Cited by 4
Metformin Use Beyond Diabetes: Reducing Cardiovascular Events In The Healthy Elderly
Xu, D. (2020) · Gerontology & Geriatric Medicine · doi:10.24966/ggm-8662/100058 · Cited by 4
Barinda, A. J., Arozal, W., & Yuasa, S. (2022) · Medical Journal of Indonesia · doi:10.13181/mji.rev.226064 · Cited by 4
Considerations Regarding Public Use of Longevity Interventions
Liu, Y. J., McIntyre, R. L., & Janssens, G. E. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.903049 · Cited by 3
Ang, S. F., Low, S. K., Ng, T. P., Tan, C. S. H., Ang, K., Lim, Z., Tang, W. E., Subramaniam, T., Sum, C. F., & Lim, S. C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220036 · Cited by 3
Self-citationMahmood, A. M., Kassid, A. A., Al-Zuaini, H. H., & Abd-Alhussain, G. K. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e124801 · Cited by 2
Montanari, C., Dong, E. L., Srinivasan, S., Leite, A. P. D. O., DeLarge, A. F., Maroteaux, M. J., Desmoulins, L. D., Menon, R., Walker, A. B., Lindsey, S. H., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf097 · Cited by 2
Exploring the Effects of Metformin on the Body via the Urine Proteome
Chen, Y. E., Wang, H., Yang, M., Shen, Z., & Gao, Y. (2025) · Biomolecules · doi:10.3390/biom15020241 · Cited by 2
Metformina: más allá de la diabetes mellitus
Díaz, C. I. E., Salazar, J. V., Anchundia, A. A., Montenegro, A. D., Altamirano, Z. M., Molina, J. J., Maigua, J. P., Lascano, X. G., & Vargas, W. V. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4092114 · Cited by 2
Preventing Dementia? Critical Perspectives on a New Paradigm of Preparing for Old Age
Leibing, A., Schicktanz, S., & SSHRC (Social Sciences and Humanities Council of Canada) (2020) · Berghahn Books · doi:10.1515/9781800734982 · Cited by 2
Fight against Glucose Rescues Age-Related Cognitive Decline
(2016) · Neuroscience Communications · doi:10.14800/nc.862 · Cited by 2
Jojo, G. M., Kuppusamy, G., Selvaraj, K., & Baruah, U. K. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00405-2 · Cited by 2
Functional Integration of Adult-Generated Neurons in Diabetic Goto-Kakizaki Rats
Damphousse, C. C., Medeiros, J. K., & Marrone, D. F. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.734359 · Cited by 2
Nolasco-Rosales, G. A., Villar-Juárez, G. E., Pérez-Osorio, D. A., Cruz-Castillo, J. D., Molina-Guzman, G., González‐Castro, T. B., Tovilla‐Zárate, C. A., Rodríguez-Sánchez, E., Mendoza, A. D. G., Hernández-Palacios, F., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.04.007 · Cited by 2
Ekblad, L. L. (2018) · UTUPub (University of Turku) · Cited by 2
Moreno, V. M. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Cognitive dysfunction: At the crossroads of glucose metabolism and vascular function
Geijselaers, S. L. C. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161005sg · Cited by 2
Sun, M., Wang, X., Lu, Z., Yang, Y., Lv, S., Miao, M., Chen, W., Wu, S., & Zhang, J. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02195-z · Cited by 1
A Growing Journey From Neurotrophins To Metabotrophins In Cardiometabolic Diseases
Aloe, L., Vinciguerra, M., Tonchev, A. B., Fiore, M., Делева, Н., Fröhlich, J., & Chaldakov, G. N. (2021) · Adipobiology · doi:10.14748/adipo.v11.8558 · Cited by 1
Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective
Abdelhafiz, A. H. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2168644 · Cited by 1
Cognitive decline and diabetes in the clinical setting
Varga, B., Tilinca, M. C., Marton, L., Ionescu, C.-N., & Szabó, M. I. M. (2024) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2653 · Cited by 1
Diabetes mellitus and neurodegenerative disorders
Amin, S. N., Albakri, K. A., Alabdallat, Y. J., & Elberry, D. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00009-9 · Cited by 1
Alzheimer’s Disease: Link to Aging and Epigenetics
Zala, D. K., Banerjee, S., & Tiwari, A. K. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_15 · Cited by 1
Zhao, Y., Wei, T., Zhao, B., Chen, Y., Wang, Z., & Tang, Y. (2025) · Aging and Disease · doi:10.14336/ad.2025.0730 · Cited by 2
Tonolo, G., Franconi, F., Caterino, M., Costanzo, M., Puci, M. V., Sotgiu, G., Tolu, F., Cherchi, S., Lodde, V., Idda, M. L., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178455 · Cited by 1
Heat Shock Proteins in Neurodegenerative Diseases
Yap, E. Y., Hou, D. L., Guan, T., Dong, X.-X., Zeng, L., Sanders, L. H., Wu, Y.-C., Tan, E., & Zhou, Z. D. (2025) · Aging and Disease · doi:10.14336/ad.2025.1309 · Cited by 1
Bafail, D. A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251410210 · Cited by 1
Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Proteinopathy
Jamerlan, A., & Hulme, J. (2026) · Molecules · doi:10.3390/molecules31060924 · Cited by 1
Metformin Regulation of the Liver Circadian Clock and Metabolic Aging: A Systems Modeling Study
Zhang, M., & Li, Y. (2026) · Metabolites · doi:10.3390/metabo16030208 · Cited by 1
Cognitive Frailty in Older Adults with Diabetes Mellitus: Bases for its Approach
Díaz-Gerevini-, G. T. (2026) · Journal of Advanced Clinical Neurology Research · doi:10.63721/26jacnr0119 · Cited by 1
Rezkalla, S. H., & Kloner, R. A. (2026) · Clinical Medicine & Research · doi:10.3121/cmr.2026.2111 · Cited by 1
Metadata
- Authors
- Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B.
- Affiliations
- National University of Singapore (SG)
- Karolinska Institutet (SE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-06-04
- Volume
- 41
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1597817261
- Cited by
- 334
- References
- 35
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 42 · 2019: 41 · 2018: 23 · 2017: 14 · 2016: 19 · 2015: 12 · 2014: 6
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Cognition Disorders, Cross-Sectional Studies, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Longitudinal Studies, Male, Metformin, Middle Aged, Prospective Studies, Singapore, Time Factors, Multivariate Analysis, Linear Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.